Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Overexpression of BRCA2 gene in sporadic breast tumours

Oncogene volume 18, pages 5232–5238 (1999)Cite this article

Abstract

The breast cancer susceptibility gene BRCA2 is expressed in a wide range of tissues as an 11-kb mRNA transcript that encodes a 3418-amino acid protein involved in the response to DNA damage. To obtain better a molecular characterization of BRCA2 expression in sporadic breast cancer, we quantified BRCA2 mRNA by means of RT – PCR in a large series of human primary breast tumours. BRCA2 expression showed wide variations in tumour tissues, being underexpressed in 14/127 (11%) and overexpressed in 25/127 (20%). BRCA2 overexpression (but not underexpression) correlated significantly with Scarff, Bloom and Richardson (SBR) histopathological grade III (P=0.007) and was mainly attributed to nuclear polymorphism (P=0.005) and mitotic index (P=0.048), suggesting that the BRCA2 gene contributes to the proliferation rate in breast tumours. BRCA2 status (under and/or overexpression versus normal expression) was not associated with subsequent relapse and with significantly shorter disease-free survival. The observed disruption of BRCA2 expression is not due to allelic loss, because the latter did not correlate with altered BRCA2 mRNA expression in our tumour series. Taken together, these data suggest the involvement, especially by overexpression, of the BRCA2 gene in sporadic breast tumours, and the existence of another important tumour-suppressor gene in breast cancer, in the 13q12-q13 region.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Beckmann MW, Picard F, An HX, van Roeyen CRC, Dominik SI, Mosny DS, Schnürch HG, Bender HG and Niederacher D. . 1996 Br. J. Cancer 73: 1220–1226.

  • Bièche I, Noguès C, Rivoilan S, Khodja A, Latil A and Lidereau R. . 1997 Br. J. Cancer 76: 1416–1418.

  • Bloom HJG and Richardson WW. . 1957 Br. J. Cancer 11: 359–377.

  • Chomczynski P and Sacchi N. . (1987) Anal. Biochem. 162: 156–159.

  • Cleton-Jansen AM, Collins N, Lakhani SR, Weissenbach J, Devilee P, Cornelisse CJ and Stratton MR. . 1995 Br. J. Cancer 72: 1241–1244.

  • Collins N, McManus R, Wooster R, Mangion J, Seal S and Lakhani SR. . 1995 Oncogene 10: 1673–1675.

  • Collins N, Wooster R and Stratton MR. . 1997 Br. J. Cancer 76: 1150–1156.

  • Couch FJ, Farid LM, DeShano ML, Tavtigian SV, Calzone K, Campeau L, Peng Y, Bogden B, Chen Q, Neuhausen S, Shattuck-Eidens D, Godwin AK, Daly MDM, Radford S, Sedlacek J, Rommens Simard J, Garber J, Merajver S and Weber BL. . 1996 Nature Genet. 13: 123–125.

  • Dirnhofer S, Berger C, Untergasser G, Geley S and Berger R. . 1995 Trends Genet. 11: 380–381.

  • EORTC Breast Cooperative Group revision. . 1980 Eur. J. Cancer 16: 1513–1515.

  • Foley KP, Leonard MW and Engel JD. . 1993 Trends Genet. 9: 380–385.

  • Gudmundsson J, Johannesdottir G, Bergthorsson JT, Arason A, Ingvarsson S and Egilsson V. . 1995 Cancer Res. 55: 4830–4832.

  • Hamann U, Herbold C, Costa S, Solomayer EF, Kaufmann M, Bastert G, Ulmer HU, Frenzel H and Komitowski D. . 1996 Cancer Res. 56: 1988–1990.

  • Kaplan EL and Meier P. . 1958 J. Am. Stat. Assoc. 53: 457–481.

  • Kelsell DP, Spurr NK, Barnes DM, Gusterson B and Bishop DT. . 1996 Lancet 347: 1554–1555.

  • Kerangueven F, Allione F, Noguchi T, Adélaïde J, Sobol H, Jacquemier J and Birnbaum D. . 1995 Genes Chrom. Cancer. 13: 291–294.

  • Lancaster JM, Wooster R, Mangion J, Phelan CM, Cochran C, Gumbs C, Seal S, Barfoot R, Collins N, Bignell G, Patel S, Hamoudi R, Larsson C, Wiseman RW, Berchuck A, Dirk Iglehart J, Stratton MR and Futreal PA. . 1996 Nature Genet. 13: 238–244.

  • Lazar V, Diez SG, Laurent A, Giovangrandi I, Radvanyi F, Chopin D, Bidart JM, Bellet D and Vidaud M. . 1995 Cancer Res. 55: 3735–3738.

  • Maniatis T, Fritsch EF and Sambook L. . (1982). In: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York pp. 458–459.

    Google Scholar 

  • Miki Y, Katagiri T, Kasumi F, Yoshimoto T and Nakamura Y. . 1996 Nature Genet. 13: 245–247.

  • Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Stano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Briston PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A and Skolnick MH. . 1994 Science 266: 66–71.

  • Mullen CA. . 1998 Am. J. Reprod. Immunol. 39: 41–49.

  • Pannetier C, Delassus S, Darche S, Saucier C and Kourilsky P. . 1993 Nucl. Acids Res. 21: 577–583.

  • Peto R, Pike MC and Armitage P. . 1977 Br. J. Cancer 35: 1–39.

  • Phelan CM, Lancaster JM, Tonin P, Gumbs C, Cochran C, Carter R, Ghadirian P, Perret C, Moslehi R, Dion F, Faucher MC, Dole K, Karimi S, Foulkes W, Lounis H, Warner E, Goss P, Anderson D, Larsson C, Narod SA and Futreal AP. . 1996 Nature Genet. 13: 120–122.

  • Rajan JV, Marquis ST, Gardner HP and Chodosh LA. . 1997 Dev. Biol. 184: 385–401.

  • Rajan JV, Wang M, Marquis ST and Chodosh LA. . 1996 Proc. Natl. Acad. Sci. USA 93: 13078–13083.

  • Sarkar G and Bolander ME. . 1994 Biotechniques 17: 864–866.

  • Sellner LN and Turbett GR. . 1996 Mol. Cell Probes 10: 481–483.

  • Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, Hoskins K, Weber B, Castilla L, Erdos M, Brody L, Friedman L, Ostermeyer E, Szabo C, King MC, Jhanwar S, Offit K, Norton L, Gilewski T, Lubin M, Osborne M, Black D, Boyd M, Steel M, Ingles S, Haile R, Lindblom A, Olsson H, Borg A, Bishop DT, Solomon E, Radice P, Spatti G, Gayther S, Ponder B, Warren W, Stratton M, Liu Q, Fujimura F, Lewis C, Skolnick MH and Goldgar DE. . 1995 JAMA 273: 535–541.

  • Spillman MA and Bowcock AM. . 1996 Oncogene 13: 1639–1645.

  • Teng DHF, Bogden R, Mitchell J, Baumgard M, Bell R, Berry S, Davis T, Ha PC, Kehrer R, Jammulapati S, Chen Q, Offit K, Skolnick MH, Tavtigian SV, Jhanwar S, Swedlund B, Wong AKC and Kamb A. . 1996 Nature Genet. 13: 241–244.

  • Thompson ME, Jensen RA, Obermiller PS, Page DL and Holt JT. . 1995 Nature Genet. 9: 444–450.

  • Van Den Berg J, Johannsson O, Hakansson S, Olsson H and Borg A. . 1996 Br. J. Cancer 74: 1615–1619.

  • Vaughn JP, Cirisano FD, Huper G, Berchuck A, Futreal PA, Marks JR and Iglehart JD. . 1996 Cancer Res. 56: 4590–4594.

  • Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rice C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Ficenec D, Kelsell D, Ford D, Tonin P, Bishop DT, Spurr NK, Ponder BAJ, Eeles RJ, Peto P, Devilee C, Cornelisse C, Lyunch H, Narod S, Lenoir G, Egilsson V, Barkadottir RB, Easton DF, Bentley DR, Futreal PA, Ashworth A and Stratton MR. . 1995 Nature 378: 789–792.

    Article  CAS  Google Scholar 

  • Zhang H, Tombline G and Weber BL. . 1998 Cell 92: 433–436.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the Comité Régional des Hauts-de-Seine de la Ligue Nationale Contre le Cancer. R Lidereau is a research director with the Institut National de la Santé et de la Recherche Médicale (INSERM). We thank A Khodja for excellent technical assistance. We also thank the Centre René Huguenin staff for assistance in specimen collection and patient care.

Author information

Authors and Affiliations

  1. Laboratoire d'Oncogénétique, Centre René Huguenin, 35 rue Dailly, St-Cloud, F-92211, France

    I Bièche & R Lidereau

  2. Département de Statistiques Médicales, Centre René Huguenin, 35 rue Dailly, St-Cloud, F-92211, France

    C Noguès

  3. Laboratoire de Génétique Moléculaire, Faculté des Sciences Pharmaceutiques et Biologiques de Paris, 4 Avenue de l'Observatoire, Paris, F-75006, France

    I Bièche

Authors
  1. I Bièche
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C Noguès
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R Lidereau
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bièche, I., Noguès, C. & Lidereau, R. Overexpression of BRCA2 gene in sporadic breast tumours. Oncogene 18, 5232–5238 (1999). https://doi.org/10.1038/sj.onc.1202903

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202903

Keywords

This article is cited by

Search

Advanced search

Quick links